Palbociclib (PAL) in combination with fulvestrant (F) in pre-/peri-menopausal (PreM) women with metastatic breast cancer (MBC) and prior progression on endocrine therapy – results from Paloma-3 - Loibl, S; Turner, N C; Ro, J (J Clin Oncol, 2016)
(Suppl.)